Advancing HIV cure research in low- and middle-income countries requires empowerment of the next generation of scientists

IF 3.5 4区 医学 Q2 IMMUNOLOGY Journal of Virus Eradication Pub Date : 2024-03-01 DOI:10.1016/j.jve.2024.100364
Roger Tatoud , R Brad Jones , Krista Dong , Thumbi Ndung'u , Steven Deeks , Caroline T. Tiemessen
{"title":"Advancing HIV cure research in low- and middle-income countries requires empowerment of the next generation of scientists","authors":"Roger Tatoud ,&nbsp;R Brad Jones ,&nbsp;Krista Dong ,&nbsp;Thumbi Ndung'u ,&nbsp;Steven Deeks ,&nbsp;Caroline T. Tiemessen","doi":"10.1016/j.jve.2024.100364","DOIUrl":null,"url":null,"abstract":"<div><p>While low- and middle-income countries (LMICs), especially in Southern and Eastern Africa, bear the largest burden of the HIV globally, investigators working on the front lines in these regions are leading a limited number of research efforts, particularly related to HIV cure. Conducting HIV cure research in high-burden HIV LIMCs provides an unparalleled opportunity to formulate innovative research strategies, design trials tailored to the local context, evaluate clinical outcomes within key and vulnerable populations, meaningful involvement of stakeholders, and to shape policies in areas where HIV prevention and cure interventions can yield the most significant impact. Further, the high prevalence of infection, with varied HIV strains affecting large diverse populations, creates a unique environment for studies that would not be feasible in any other part of the world. This underscores the critical importance of addressing obstacles to unlock the full potential of research efforts in these regions. In this viewpoint, we identify significant challenges facing early career investigators in LMICs, particularly in Africa, that hinder their full engagement in HIV cure research. Drawing examples from the International AIDS Society's Research-for-Cure Academy, we provide practical recommendations to overcome barriers that include limited access to funding, effective mentors, educational and career development opportunities, coupled with inadequate investment in infrastructure that contribute towards the limited number of investigators from high-burden HIV LIMCs who are spearheading cutting-edge cure research. Addressing these challenges is crucial to empower investigators who possess unique insights and expertise, and who are well positioned to lead HIV cure-related research efforts. We acknowledge and welcome initiatives that promote capacity building and knowledge exchange between early-career investigators in LMICs and their peers and scientific leaders from high-income countries (HICs). Prioritizing investment in global collaboration and partnership will play a pivotal role in empowering the next generation of African scientists and clinicians. To expedite advancements of cure-related strategies that will be effective in high-burden HIV LMICs, we endorse the sustainable expansion of these pivotal initiatives in these regions, to enhance their effectiveness and hasten progress in the pursuit of a global HIV cure.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 1","pages":"Article 100364"},"PeriodicalIF":3.5000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000013/pdfft?md5=e23db47f15f7445a70060b4c2494b4a7&pid=1-s2.0-S2055664024000013-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Virus Eradication","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2055664024000013","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

While low- and middle-income countries (LMICs), especially in Southern and Eastern Africa, bear the largest burden of the HIV globally, investigators working on the front lines in these regions are leading a limited number of research efforts, particularly related to HIV cure. Conducting HIV cure research in high-burden HIV LIMCs provides an unparalleled opportunity to formulate innovative research strategies, design trials tailored to the local context, evaluate clinical outcomes within key and vulnerable populations, meaningful involvement of stakeholders, and to shape policies in areas where HIV prevention and cure interventions can yield the most significant impact. Further, the high prevalence of infection, with varied HIV strains affecting large diverse populations, creates a unique environment for studies that would not be feasible in any other part of the world. This underscores the critical importance of addressing obstacles to unlock the full potential of research efforts in these regions. In this viewpoint, we identify significant challenges facing early career investigators in LMICs, particularly in Africa, that hinder their full engagement in HIV cure research. Drawing examples from the International AIDS Society's Research-for-Cure Academy, we provide practical recommendations to overcome barriers that include limited access to funding, effective mentors, educational and career development opportunities, coupled with inadequate investment in infrastructure that contribute towards the limited number of investigators from high-burden HIV LIMCs who are spearheading cutting-edge cure research. Addressing these challenges is crucial to empower investigators who possess unique insights and expertise, and who are well positioned to lead HIV cure-related research efforts. We acknowledge and welcome initiatives that promote capacity building and knowledge exchange between early-career investigators in LMICs and their peers and scientific leaders from high-income countries (HICs). Prioritizing investment in global collaboration and partnership will play a pivotal role in empowering the next generation of African scientists and clinicians. To expedite advancements of cure-related strategies that will be effective in high-burden HIV LMICs, we endorse the sustainable expansion of these pivotal initiatives in these regions, to enhance their effectiveness and hasten progress in the pursuit of a global HIV cure.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在中低收入国家推进艾滋病毒治愈研究需要增强下一代科学家的能力
中低收入国家(LMICs),尤其是南部和东部非洲国家,承受着全球最大的艾滋病毒负担,但在这些地区一线工作的研究人员领导着数量有限的研究工作,尤其是与艾滋病毒治愈相关的研究工作。在艾滋病毒高负担的 LIMC 开展艾滋病毒治愈研究提供了一个无与伦比的机会,可以制定创新的研究战略,设计适合当地情况的试验,评估关键人群和易感人群的临床结果,让利益相关者切实参与进来,并在艾滋病毒预防和治愈干预措施可以产生最重大影响的领域制定政策。此外,由于感染率高,不同的艾滋病毒菌株影响着大量不同的人群,这为研究创造了独特的环境,这在世界其他任何地方都是不可行的。这凸显了解决这些地区研究工作中的障碍以充分发挥其潜力的极端重要性。在本观点中,我们指出了低收入与中等收入国家(尤其是非洲)的早期职业研究人员所面临的重大挑战,这些挑战阻碍了他们全面参与艾滋病治愈研究。我们从国际艾滋病学会治愈研究学院(Research-for-Cure Academy)的实例出发,提出了克服障碍的实用建议,这些障碍包括获得资金、有效指导、教育和职业发展机会的途径有限,以及基础设施投资不足,这些因素导致来自艾滋病高负担低收入国家和地区的研究人员数量有限,而这些研究人员正在率先开展尖端的艾滋病治愈研究。应对这些挑战对于增强调查人员的能力至关重要,因为他们拥有独特的见解和专业知识,完全有能力领导与艾滋病治愈相关的研究工作。我们认可并欢迎那些促进低收入与中等收入国家(LMICs)的早期研究人员与高收入国家(HICs)的同行和科学领袖进行能力建设和知识交流的倡议。优先投资于全球合作和伙伴关系将在增强下一代非洲科学家和临床医生的能力方面发挥关键作用。为了加快推进艾滋病毒治愈相关战略,使其在艾滋病毒高负担的低收入与中等收入国家(LMIC)有效,我们支持在这些地区可持续地扩大这些关键举措,以提高其有效性,加快全球艾滋病毒治愈工作的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Virus Eradication
Journal of Virus Eradication Medicine-Public Health, Environmental and Occupational Health
CiteScore
6.10
自引率
1.80%
发文量
28
审稿时长
39 weeks
期刊介绍: The Journal of Virus Eradication aims to provide a specialist, open-access forum to publish work in the rapidly developing field of virus eradication. The Journal covers all human viruses, in the context of new therapeutic strategies, as well as societal eradication of viral infections with preventive interventions. The Journal is aimed at the international community involved in the prevention and management of viral infections. It provides an academic forum for the publication of original research into viral reservoirs, viral persistence and virus eradication and ultimately development of cures. The Journal not only publishes original research, but provides an opportunity for opinions, reviews, case studies and comments on the published literature. It focusses on evidence-based medicine as the major thrust in the successful management of viral infections.The Journal encompasses virological, immunological, epidemiological, modelling, pharmacological, pre-clinical and in vitro, as well as clinical, data including but not limited to drugs, immunotherapy and gene therapy. It is an important source of information on the development of vaccine programs and preventative measures aimed at virus eradication.
期刊最新文献
Editorial Board Knowledge and attitude among Bangladeshi healthcare workers regarding the management and infection prevention and control of Nipah virus A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs Partner protections in HIV cure-related trials involving analytical treatment interruption: Updated toolkit to mitigate HIV transmission risk Indomethacin inhibits human seasonal coronaviruses at late stages of viral replication in lung cells: Impact on virus-induced COX-2 expression
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1